The DNA sequence and comparative analysis of human chromosome 10
Panos Deloukas(Wellcome Sanger Institute), M. E. Earthrowl(Wellcome Sanger Institute), Darren Grafham(Wellcome Sanger Institute), Marc Rubenfield(NKT Therapeutics (United States)), Lisa French(Wellcome Sanger Institute), Charles A. Steward(Wellcome Sanger Institute), Sarah Sims(Wellcome Sanger Institute), Matt Jones(Wellcome Sanger Institute), S. Searle(Wellcome Sanger Institute), Carol Scott(Wellcome Sanger Institute), Kevin Howe(Wellcome Sanger Institute), Sarah Hunt(Wellcome Sanger Institute), T. Daniel Andrews(Wellcome Sanger Institute), James Gilbert(Wellcome Sanger Institute), David Swarbreck(Wellcome Sanger Institute), Jennifer Ashurst(Wellcome Sanger Institute), Amy Taylor(Wellcome Sanger Institute), J K Battles(NKT Therapeutics (United States)), Christine Bird(Wellcome Sanger Institute), R. Ainscough(Wellcome Sanger Institute), J. P. Almeida(Wellcome Sanger Institute), R. I. S. Ashwell(Wellcome Sanger Institute), K. D. Ambrose(Wellcome Sanger Institute), Anne Babbage(Wellcome Sanger Institute), C. L. Bagguley(Wellcome Sanger Institute), J. Bailey(Wellcome Sanger Institute), Ruby Banerjee(Wellcome Sanger Institute), K. Bates(Wellcome Sanger Institute), Helen Beasley(Wellcome Sanger Institute), S. Bray-Allen(Wellcome Sanger Institute), Andrew Brown(Wellcome Sanger Institute), J. Y. Brown(Wellcome Sanger Institute), D. C. Burford(Wellcome Sanger Institute), W. Burrill(Wellcome Sanger Institute), J.H. Burton(Wellcome Sanger Institute), Patrick Cahill(NKT Therapeutics (United States)), D. Camire(NKT Therapeutics (United States)), N. P. Carter(Wellcome Sanger Institute), J. C. Chapman(Wellcome Sanger Institute), S. Y. Clark(Wellcome Sanger Institute), Geraldine M Clarke(Wellcome Sanger Institute), Chris M. Clee(Wellcome Sanger Institute), S. Clegg(Wellcome Sanger Institute), N. Corby(Wellcome Sanger Institute), Alan Coulson(Wellcome Sanger Institute), Pawandeep Dhami(Wellcome Sanger Institute), Ireena Dutta(Wellcome Sanger Institute), Matt Dunn(Wellcome Sanger Institute), L. Faulkner(Wellcome Sanger Institute), Adam Frankish(Wellcome Sanger Institute), Julie Frankland(Wellcome Sanger Institute), P. Garner(Wellcome Sanger Institute), J. Garnett(Wellcome Sanger Institute), Susan Gribble(Wellcome Sanger Institute), Chris Griffiths(Wellcome Sanger Institute), Russell Grocock(Wellcome Sanger Institute), Erik Gustafson(BioScience Laboratories (United States)), S. Austin Hammond(Wellcome Sanger Institute), Joanna Harley(Wellcome Sanger Institute), Elizabeth A. Hart(Wellcome Sanger Institute), P. D. Heath(Wellcome Sanger Institute), T. P. Ho(NKT Therapeutics (United States)), Barbara Hopkins(Wellcome Sanger Institute), Jane Anne Horne(NKT Therapeutics (United States)), Philip Howden(Wellcome Sanger Institute), Elizabeth J. Huckle(Wellcome Sanger Institute), Catherine Hynds(NKT Therapeutics (United States)), Christopher M. Johnson(Wellcome Sanger Institute), David J. Johnson(Wellcome Sanger Institute), A. Kana(Wellcome Sanger Institute), Mike Kay(Wellcome Sanger Institute), A. M. Kimberley(Wellcome Sanger Institute), J. K. Kershaw(Wellcome Sanger Institute), Maria Kokkinaki(Foundation for Research and Technology Hellas), Gavin K. Laird(Wellcome Sanger Institute), Stephanie Lawlor(Wellcome Sanger Institute), H. M. Lee(NKT Therapeutics (United States)), Daniel Leongamornlert(Wellcome Sanger Institute), Gavin K. Laird(Wellcome Sanger Institute), Christine Lloyd(Wellcome Sanger Institute), David Lloyd(Wellcome Sanger Institute), Jane Loveland(Wellcome Sanger Institute), J. Lovell(Wellcome Sanger Institute), Stuart McLaren(Wellcome Sanger Institute), K. E. McLay(Wellcome Sanger Institute), Amanda A. McMurray(Wellcome Sanger Institute), M. Mashreghi-Mohammadi(Wellcome Sanger Institute), L. Matthews(Wellcome Sanger Institute), Sarah Milne(Wellcome Sanger Institute), T. Nickerson(Wellcome Sanger Institute), Minh Quang Nguyen(Wellcome Sanger Institute), E. K. Overton-Larty(Wellcome Sanger Institute), Sophie Palmer(Wellcome Sanger Institute), A. V. Pearce(Wellcome Sanger Institute), A. I. Peck(Wellcome Sanger Institute), Sarah Pelan(Wellcome Sanger Institute), Benjamin Phillimore(Wellcome Sanger Institute), Keith Porter(Wellcome Sanger Institute), Catherine M. Rice(Wellcome Sanger Institute), Andrea Rogosin(NKT Therapeutics (United States)), M. T. Ross(Wellcome Sanger Institute), Theologia Sarafidou(Institute of Molecular Biology and Biotechnology), Harminder Sehra(Wellcome Sanger Institute), R. Shownkeen(Wellcome Sanger Institute), C. D. Skuce(Wellcome Sanger Institute), Michelle Smith(Wellcome Sanger Institute), Lorraine S. Standring(NKT Therapeutics (United States)), Neil Sycamore(Wellcome Sanger Institute), J. Tester(Wellcome Sanger Institute), A. Thorpe(Wellcome Sanger Institute), W. Torcasso(NKT Therapeutics (United States)), Alan Tracey(Wellcome Sanger Institute), A. Tromans(Wellcome Sanger Institute), Jason M. Tsolas(BioScience Laboratories (United States)), M. Wall(Wellcome Sanger Institute), Justine Walsh(NKT Therapeutics (United States)), H. Wang(NKT Therapeutics (United States)), Keith G. Weinstock(NKT Therapeutics (United States)), Anthony P. West(Wellcome Sanger Institute), David L. Willey(Wellcome Sanger Institute), Siobhan Whitehead(Wellcome Sanger Institute), Laurens Wilming(Wellcome Sanger Institute), P. W. Wray(Wellcome Sanger Institute), Lynn Young(Wellcome Sanger Institute), Y. Chen(European Bioinformatics Institute), Ruth C. Lovering(University College London), Nicholas Κ. Moschonas(Foundation for Research and Technology Hellas), Reiner Siebert(University Hospital Schleswig-Holstein), Kim Fechtel(NKT Therapeutics (United States)), D. R. Bentley(Wellcome Sanger Institute), Richard Durbin(Wellcome Sanger Institute), Tim Hubbard(Wellcome Sanger Institute), Lynn Doucette‐Stamm(BioScience Laboratories (United States)), Stephan Beck(Wellcome Sanger Institute), Doug Smith(BioScience Laboratories (United States)), Jane Rogers(Wellcome Sanger Institute)
Cited by 84Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis